Citations

Showing 10 of 108152 citations.

Guillain-Barré Syndrome After Acute Hepatitis E Infection: A Case Report and Literature Review
Rose, Mariah Q., Santos, Christan D. , Rubin, Devon I., Siegel, Jason , Siegel, Jason L, Freeman, William D.

Mayo Clinic

Critical Care Nurse | August 1, 2021 | Volume: 41 | Issue: 4 | Pages: 47-53

10.4037/ccn2021129 | PMID 34333618 Get It

IntroductionGuillain-Barré syndrome precipitated by hepatitis E virus infection is rare, yet its incidence is increasing.Clinical FindingsA 57-year-old man was transferred from another facility with fatigue, orange urine, and progressive weakness over 4 to 6 weeks. Initial laboratory results included total bilirubin, 9.0 mg/dL; direct bilirubin, 6.4 mg/dL; aspartate aminotransferase, 1551 U/L; alanine aminotransferase, 3872 U/L; and alkaline phosphatase, 430 U/L. Immunoglobulin M and quantitative polymerase chain reaction test results were positive for hepatitis E virus. Contrast-enhanced magnetic resonance imaging of the brain and spine showed no gross abnormalities. Analysis of cerebrospinal fluid obtained by lumbar puncture revealed the following (reference values in parentheses): total white blood cell count, 15/μL (0–5/μL), with 33% neutrophils and 54% lymphocytes; protein, 0.045 g/dL (0.015–0.045 g/dL); and glucose, 95 mg/dL (within reference range). Neurological examination revealed weakness in both upper extremities, with proximal strength greater than distal strength. The patient could not elevate either lower extremity off the bed and had areflexia and reduced sensation throughout all extremities.DiagnosisGuillain-Barré syndrome secondary to acute hepatitis E virus infection was diagnosed on the basis of clinical characteristics, serum and cerebrospinal fluid analyses, and nerve conduction studies.ConclusionsNurses and clinicians should obtain a thorough history and consider hepatitis E virus infection as a precipitating factor in patients with sensory and motor disturbances consistent with Guillain-Barré syndrome. The case gives insight into the diagnostic process for Guillain-Barré syndrome and highlights the vital role of bedside nurses in evaluating and treating these patients.
Mechanical Thrombectomy of Carotid Terminus Occlusion Using Direct Aspiration Technique—Video Illustration: 2-Dimensional Operative Video
Kasab, Sami Al , Sattur, Mithun G. , Spiotta, Alejandro M , Group, ENRG, Bain, Mark, Bendock, Bernard, Binning, Mandy J., Boulos, Alan S. , Crowley, Webster, Fessler, Richard D., Guterman, Lee R., Hoit, Daniel , Hopkins, L. Nelson , Howington, Jay U., James, Robert F. , Jankowitz, Brian T. , Kan, Peter , Khalessi, Alex A, Kim, Louis J. , Langer, David J. , Levitt, Michael R. , Mack, William J. , Mericle, Robert A., Ogilvy, Chris, Replogle, Robert, Riina, Howard A. , Ringer, Andrew J. , Rodríguez, Rafael, Saugaveau, Eric, Schirmer, Clemens M. , Spiotta, Alex, Sultan, Ali, Turner, Raymond D , Veznedaroglu, Erol, Welch, Babu G. , White, Jonathan, Ogilvy, Christopher S. , Levitt, Michael R , Schirmer, Clemens M , Ogilvy, Christopher S , Porto, Guilherme , Group, ENRG, Arthur, Adam Stephen , Grande, Andrew Walker , Hanel, Ricardó A. , Kim, Louis J. , Lanzino, Giuseppe , Levy, Elad I. , Lopes, Demetrius K. , Mocco, J , Pandey, Aditya S , Rodriguez, Rafael, Siddiqui, Adnan H. , Tawk, Rabih G. , Thomas, Ajith J , White, Jonathan A.

Mayo Clinic

Operative Neurosurgery | July 31, 2021 | Volume: 21 | Issue: 5 | Pages: E441-E442

10.1093/ons/opab272 | PMID 34332504 Get It

Abstract Acute carotid terminus occlusion (CTO) is responsible for up to 5% of acute ischemic strokes secondary to emergent large vessel occlusion (ELVO) and up to 20% of acute internal carotid artery (ICA) occlusions. 1 The term “CTO” has also been used to describe occlusions in the supra-clinoid segment or at the bifurcation of the ICA. Compared to other ELVOs, patients with CTO present with higher stroke severity and larger infarct volume, likely to be a result of disruption of direct Circle of Willis collaterals across the anterior communicating artery (AComA) and posterior communicating artery (PComA). 2,3 Similary, CTO is usually associated with worse prognosis compared to other ELVOs in general. With regard to response to treatment, previous studies have reported significantly lower recanalization rates with intravenous alteplase with CTO compared to M1 segment occlusion. With regard to the safety and efficacy of mechanical thrombectomy, prior reports provide conflicting results with some reporting lower successful recanalization rates with CTO compared to M1 occlusion, and others reporting similar results. In our experience, we have found that successful recanalization of CTO can be achieved with a similar approach to M1 occlusions utilizing a direct aspiration first pass technique (ADAPT). 3,4 Herein, we present a case of CTO for which we performed mechanical thrombectomy using ADAPT. This procedure was an emergent standard of care procedure for which a consent was not required and so not obtained.
Microsurgical Resection of Dorsal Pontine Cavernous Malformation: The Telovelar Approach Augmented by the Tonsillouvular Fissure Exposure: 2-Dimensional Operative Video
Patra, Devi Prasad, Turcotte, Evelyn L. , Bendok, Bernard R. , Patra, Devi P. , Bendok, Bernard R

Mayo Clinic

Operative Neurosurgery | July 31, 2021 | Volume: 21 | Issue: 4 | Pages: E373-E374

10.1093/ons/opab264 | PMID 34332499 Get It

Abstract Surgical approaches to lesions of the fourth ventricle (FV) have been modified over the years to reduce the complications associated with splitting the inferior cerebellar vermis (ICV) and disrupting the brainstem and critical surrounding structures. 1-4 Two common approaches to lesions of this region include the transvermian approach (TVA) and telovelar approach (TeVA). 2 The TVA was initially considered the conventional route of access to lesions of the FV 1 but has been associated with significant risks, including possible gait ataxia and dysarthria. 3 The TeVA is advantageous, as it involves dissection along natural clefts and division of non-neural tissue and provides good exposure of the superolateral recess with modest exposure of the rostral FV. The TeVA approach can be augmented by opening the tonsilouvular fissures (TUFs). This added dissection allows greater lateral and superior exposure with less need for retraction. In this operative video, we demonstrate a case in which we augmented the TeVA with a TUF dissection to access a dorsal pontine cavernous malformation. We performed a midline suboccipital craniotomy with a C1 posterior laminectomy. TUF dissection was followed by division of the tela choroidea (TC), which allowed for more lateral exposure of the FV and excellent visualization of the cavernous malformation without the need to traverse neural tissue. TeVA augmented by TUF dissection provided adequate access to the dorsal pons for complete resection of the cavernous malformation. The patient consented to the procedure as shown in this operative video and gave informed written consent for use of her images in publication. Anatomic images provided by courtesy of © The Rhoton Collection. http://rhoton.ineurodb.org/. Video © Mayo Foundation for Medical Education and Research, 2021. Used with permission.
Final 3‐year clinical outcomes following transcatheter aortic valve implantation with a supra‐annular self‐expanding repositionable valve in a real‐world setting: Results from the multicenter FORWARD study
Mieghem, Nicolas M. Van , Windecker, Stephan , Manoharan, Ganesh, Bosmans, Johan, Modine, Thomas , Linke, Axel, Scholtz, Werner , Tchétché, Didier , Finkelstein, Ariel, Eisenberg, Ruth , Grube, Eberhard, Van Mieghem, Nicolas M , Modine, Thomas , Ito, Saki , Windecker, Stephan , Bleiziffer, Sabine

Mayo Clinic

Catheterization and Cardiovascular Interventions | July 31, 2021 | Volume: 99 | Issue: 1 | Pages: 171-178

10.1002/ccd.29889 | PMID 34331844 Get It

AbstractObjectivesThe Evolut R FORWARD study confirmed safety and effectivenesss of the Evolut R THV in routine clinical practice out to 1 year. Herein, we report the final 3‐year clinical follow up of the FORWARD study.BackgroundTranscatheter aortic valve replacement (TAVR) is a proven alternative to surgery in elderly patients with symptomatic severe aortic stenosis. Long‐term clinical outcome data with the Evolut R platform are scarce.MethodsFORWARD is a prospective multicenter observational study that evaluated the Evolut R system in routine clinical practice at 53 centres. Eligible patients had symptomatic native aortic valve stenosis or failed surgical aortic bioprosthesis and elevated operative risk per Heart‐Team assessment. TAVR was attempted in 1039 patients.ResultsMean age was 81.8 ± 6.2 years, 64.9% were women, STS score was 5.5 ± 4.5% and 34.2% were frail. Rates of all‐cause mortality and disabling stroke were 24.8% and 4.8% at 3 years. Early need for a new pacemaker implantation after TAVR (all‐cause mortality: with new PPI; 21.0% vs. without; 22.8%, p = 0.55) and the presence of > trace paravalvular regurgitation (all‐cause mortality: no or trace; 22.0% vs. ≥ mild; 25.5%, p = 0.29) did not affect survival. Between 1 and 3 years incidence rates of valve related intervention, endocarditis and clinically relevant valve thrombosis were low.ConclusionsThe Evolut R valve maintained a favorable safety profile through 3 years in routine clinical practice. Rates of transcatheter heart valve‐related adverse events were low.
Editorial: trends in alcohol use and alcohol‐associated liver disease in the US population—authors' reply
Singal, Ashwani K. , Arsalan, Arshad, Wong, Robert J. , Kuo, Yong‐Fang, Kamath, Patrick S. , Shah, Vijay H. , Wong, Robert J , Singal, Ashwani K , Dunn, Winston , Arab, Juan Pablo , Kuo, Yong‐Fang

Mayo Clinic

Alimentary Pharmacology & Therapeutics | July 31, 2021 | Volume: 54 | Issue: 4 | Pages: 513-514

10.1111/apt.16520 | PMID 34331802 Get It

LINKED CONTENTThis article is linked to Singal et al and Barnard & Dave papers. To view these articles, visit https://doi.org/10.1111/apt.16461 and https://doi.org/10.1111/apt.16491
Updated results of the placebo‐controlled, phase III JAKARTA trial of fedratinib in patients with intermediate‐2 or high‐risk myelofibrosis
Pardanani, Animesh , Tefferi, Ayalew , Masszi, Tamás , Mishchenko, Elena, Drummond, Mark W., Jourdan, Éric , Jurgutis, Mindaugas, Rambaldi, Alessandro , Koh, Liang Piu , Rose, Shelonitda, Harrison, Claire , Rambaldi, Alessandro , Masszi, Tamas , Vannucchi, Alessandro M. , Ribrag, Vincent , Zhang, Jun

Mayo Clinic

British Journal of Haematology | July 31, 2021 | Volume: 195 | Issue: 2 | Pages: 244-248

10.1111/bjh.17727 | PMID 34331348 Get It

SummaryFedratinib, an oral Janus kinase‐2 (JAK2) inhibitor, reduces splenomegaly and improves symptom burden in patients with myelofibrosis. Regulatory approval of fedratinib 400‐mg daily was based on results of an updated analysis of the pivotal phase III, placebo‐controlled JAKARTA trial in patients with JAK‐inhibitor‐naïve myelofibrosis. At week 24, spleen volume response rate was 47% and symptom response rate was 40% with fedratinib 400 mg, versus 1% and 9% respectively, with placebo. Common adverse events were diarrhoea, nausea, anaemia, and vomiting. No Wernicke encephalopathy occurred in patients receiving fedratinib 400 mg/day. These updated data support use of first‐line fedratinib in patients with myelofibrosis.
A systematic review and gap analysis of frailty and oral health characteristics in older adults: A call for clinical translation
Slashcheva, Lyubov , Karjalahti, Erika, Hassett, Leslie C. , Smith, Barbara J. , Slashcheva, Lyubov D , Hassett, Leslie C , Smith, Barbara, Chamberlain, Alanna M.

Mayo Clinic

Gerodontology | July 31, 2021 | Volume: 38 | Issue: 4 | Pages: 338-350

10.1111/ger.12577 | PMID 34331353 Get It

AbstractObjectiveThis systematic review updates the evidence for association between oral health characteristics and frailty status, identifying gaps in translational dental research and application of frailty assessment into clinical practice.BackgroundClinicians have little guidance on stage‐appropriate dental treatment for medically complex older adults. Oral health characteristics have been associated with frailty status, determined through validated assessment tools representing a concise measure of health. Translation of frailty assessment into dental practice has not been the focus of previous reviews.MethodsUtilising the PRISMA framework for systematic reviews, a comprehensive database search identified articles describing the association of interest. Those included were cross‐sectional or longitudinal, in English, included participants aged 50 years or older, used validated frailty assessments and measured clinically relevant oral health outcomes. From 835 screened articles, 26 full‐text articles were eligible for quality appraisal and synthesis.ResultsFrailty prevalence ranged from 8.5% to 66.0%. Most studies utilised the Fried frailty criteria. Qualitative synthesis of 17 cross‐sectional and nine longitudinal studies demonstrated significant covariate‐adjusted association between frailty status and number of teeth, chewing ability, prosthetic characteristics, dental caries, periodontitis, dental utilisation and oral health‐related quality of life factors. Variability in findings reflected study sample diversity based on country of study origin, age at recruitment, sample size, frailty assessment type, use of clinical versus self‐reported outcome measures and differences in statistical analysis.ConclusionDespite robust evidence of association with oral health characteristics, frailty assessment has yet to be sufficiently applied to translational dental research and clinical practice.
Outcomes of Surface Replacement Arthroplasty in Metacarpophalangeal Joints Affected by Noninflammatory Arthritis
Mohney, Brian G. , Rizzo, Marco , Claxton, Matthew R , Rizzo, Marco , Wagner, Eric R.

Mayo Clinic

HAND | July 31, 2021 | Volume: 18 | Issue: 3 | Pages: 463-468

10.1177/15589447211028917 | PMID 34330177 Get It

Background The purpose of this study was to investigate the outcomes of surface replacement arthroplasty (SRA) for noninflammatory arthritis of the metacarpophalangeal (MCP) joint. Methods Records from 20 SRAs performed between 1995 and 2017 in 17 patients with noninflammatory arthritis affecting the MCP joint were retrospectively reviewed. The mean follow up was 6.6 years. Results Three arthroplasties (15%) underwent 4 revision operations. The 2-, 5-, 10-, and 15-year rates of survival from surface replacement implant revision were 90%, 90%, 79%, and 79%, respectively. Major complications occurring in revised joints included arthrodesis (n = 1) and amputation (n = 1). The overall reoperation rate was 35%. The 2-, 5-, 10-, and 15-year rates of overall reoperation-free survival were 75%, 69%, 60%, and 60%, respectively. Conclusions Pain ratings and MCP arc of motion significantly improved following arthroplasty. Metacarpophalangeal SRA for noninflammatory arthritis can improve arc of motion and pain. Revision is uncommon; however, 1 in 3 joints requires reoperation.
Gut microbiota: a target for intervention in obesity
Sehgal, Kanika , Khanna, Sahil

Mayo Clinic

Expert Review of Gastroenterology & Hepatology | July 30, 2021 | Volume: 15 | Issue: 10 | Pages: 1169-1179

10.1080/17474124.2021.1963232 | PMID 34329563 Get It

Teledentistry in the management of a non‐Hodgkin's lymphoma manifesting as a gingival swelling: A case report
Zhou, Miao Xian , Johnson, Emma F. , Arce, Kevin , Gruwell, Scott F., Zhou, Miao Xian

Mayo Clinic

Special Care in Dentistry | July 30, 2021 | Volume: 42 | Issue: 1 | Pages: 86-90

10.1111/scd.12638 | PMID 34329504 Get It

AbstractOral cavity lymphomas constitute only 3% of all lymphomas in the general population but are the third most common oral malignancy. A 67‐year‐old female with a history of osteoporosis, Graves’ disease and non‐Hodgkin's lymphoma was referred to the Department of Dental Specialties with a chief complaint of persistent soft tissue swelling facial to the maxillary incisors of possible non‐odontogenic origin. To expedite care, the patient was first seen via teledentistry and subsequently appointed for an in‐person evaluation and treatment. Examination revealed 1–3 mm probing depths and a firm, non‐tender, non‐fluctuant mass in the facial soft tissues approximating teeth nos. 7–10. Biopsy of the affected area was performed. A diagnosis of recurrent follicle center cell lymphoma, a form of non‐Hodgkin's lymphoma, was rendered. The patient was subsequently referred to the Oncology and Hematology team, followed for 6 weeks and remained symptom‐free. This case underlies the importance of teledentistry to expedite care and manage patient expectations. Additionally, it also underscores the importance of microscopic examination of tissue samples from oral lesions that appear non‐odontogenic in nature and reinforces the role of dentistry in uncovering the oral‐systemic link.